Bloomberg the Company & Products

Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last $138.61 USD
Change Today +0.22 / 0.16%
Volume 472.1K
SIAL On Other Exchanges
As of 8:10 PM 04/20/15 All times are local (Market data is delayed by at least 15 minutes).

sigma-aldrich (SIAL) Snapshot

Previous Close
Day High
Day Low
52 Week High
04/20/15 - $139.15
52 Week Low
04/23/14 - $93.74
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for SIGMA-ALDRICH (SIAL)

sigma-aldrich (SIAL) Related Businessweek News

No Related Businessweek News Found

sigma-aldrich (SIAL) Details

Sigma-Aldrich Corporation, a life science and high technology company, develops, manufactures, purchases, and distributes various chemicals, biochemicals, and equipment products worldwide. The company provides chemical products, reagents, and kits and services are used in scientific research, including genomic and proteomic research, biotechnology, pharmaceutical development, and diagnosis of disease; and as key components in pharmaceutical, diagnostics, and high technology manufacturing. It offers media and critical raw materials for industrial cell culture, contract manufacturing services, pharmaceutical safety testing services, and organometallic precursors for semiconductor manufacturing. The company sells its products to pharmaceutical companies, universities, commercial laboratories, industrial companies, biotechnology companies, non-profit organizations, governmental institutions, diagnostic, chemical and electronics companies, and hospitals. Sigma-Aldrich Corporation was founded in 1951 and is based in St. Louis, Missouri.

9,300 Employees
Last Reported Date: 02/12/15
Founded in 1951

sigma-aldrich (SIAL) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $1.0M
Chief Financial Officer and Executive Vice Pr...
Total Annual Compensation: $485.4K
Executive Vice President and President of App...
Total Annual Compensation: $455.7K
Executive Vice President and President of SAF...
Total Annual Compensation: $404.2K
Executive Vice President and President of The...
Total Annual Compensation: $369.2K
Compensation as of Fiscal Year 2014.

sigma-aldrich (SIAL) Key Developments

Sigma-Aldrich Corp to Opens Asia Pacific Headquarters and a New Distribution Center in Tuas

Sigma-Aldrich Corp. is expanding its investment in the Asia Pacific region, opening a new headquarters and cell culture center in Singapore as well as a new distribution center in Tuas. The company's new Asia Pacific HQ and cell culture technical center are located in Singapore's Biopolis Research Park. The new HQ facility brings existing commercial office and production laboratories in Singapore into one central location, according to a statement from the company. The cell culture technical center will support customers in Sigma-Aldirch's SAFC commercial business in biopharmaceutical development and manufacturing. Sigma-Aldrich also plans to construct its own distribution center in Tuas, which will be the company's first full-owned distribution center in South East Asia. The center is expected to be open at the end of the year.

SAFC Commercial Launches New EX-CELL® Advanced(TM) Products for Scalable, Efficient Biopharmaceutical Manufacturing

SAFC Commercial launched the EX-CELL® Advanced™ product line. Designed to address the needs of an evolving industry where speed to market is paramount, the new product line provides for increased performance, streamlines regulatory compliance, and offers the supply chain security needed in today's biopharmaceutical environment. The first EX-CELL Advanced product is the high-performing batch media system developed for a range of widely used industrial CHO cell lines, including SAFC's proprietary CHOZN® cell line. During rigorous testing, the EX-CELL Advanced CHO Fed-batch System outperformed other commercially available equivalents by displaying significantly higher titers. Robust scale up and effortless adaptation offers those in biopharmaceutical development the opportunity to get their process up and running quickly and efficiently. Protein quality, another vital consideration in the development process, remains uncompromised.

Eric M. Green to Resign as Executive Vice President and President of Sigma-Aldrich Corporation's Research Business Unit, Effective April 23, 2015

On April 13, 2015, Eric M. Green, Executive Vice President and President of the Research Business Unit, notified Sigma-Aldrich Corporation that he will resign from the company, effective April 23, 2015. Dr. Frank Wicks will take over leadership of the Research Business Unit in addition to his duties as President of the Applied Business Unit.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
SIAL:US $138.61 USD +0.22

SIAL Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Dr Reddy's Laboratories Ltd 3,567 INR -80.15
International Flavors & Fragrances Inc $117.67 USD +1.39
Symrise AG €57.62 EUR +0.81
UCB SA €69.71 EUR +0.74
Waters Corp $124.02 USD -0.39
View Industry Companies

Industry Analysis


Industry Average

Valuation SIAL Industry Range
Price/Earnings 33.2x
Price/Sales 5.9x
Price/Book 5.3x
Price/Cash Flow 33.1x
TEV/Sales 5.4x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact SIGMA-ALDRICH, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at